When it comes to biotech plays, the author of today’s article advises that there are two investors should know: “The first is to buy stock in a company that’s very new but that is targeting an unexploited and niche market, typically in the form of a rare and untreated disease… [and] the second strategy is to invest in an older company that’s on the verge of approval with a product targeting a similar market”. With that, they proceed to highlight one biotech stock to consider right now for each of these plays. For more, CLICK HERE.
2 Biotech Plays To Know – And 1 Stock For Each Play Right Now
- by RobH
